NEW YORK (GenomeWeb News) – Zygem and Phthisis Diagnostics announced Thursday that they will collaborate on developing products for the detection of infectious pathogens in complex samples, such as stool, blood, and water.

The partnership will combine Zygem's enzymatic nucleic acid extraction technology with Phthisis' molecular diagnostic test expertise to develop products that can rapidly obtain high-quality DNA from infectious pathogens. The firms will initially focus on extracting pathogen DNA from stool.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.